Both in vitro and in vivo investigations have demonstrated that exogenous supplementation of PEDF plays a pivotal role in combating VEGF-induced pathology and oxidative stress, while also regulating matrix metalloproteinases in conditions such as diabetic retinopathy and nephropathy. The gene discussed is VEGFA; the disease is kidney disorder.